Lisdexamfetamine, marketed as Vyvanse, is a controlled medication approved for attention deficit hyperactivity disorder in children and grown-ups . In Canada, its access is strictly regulated by Health https://sandozlisdexamfetamineon128611.oblogation.com/41912911/lisdexamfetamine-in-canada-a-comprehensive-guide